Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects. [electronic resource]
- The Journal of infectious diseases Oct 2012
- 1002-11 p. digital
Adult Aged Area Under Curve Drug Therapy, Combination Female HIV Fusion Inhibitors--adverse effects HIV Infections--blood HIV Protease Inhibitors--therapeutic use HIV-1--drug effects Humans Inhibitory Concentration 50 Male Middle Aged Organophosphates--adverse effects Piperazines--adverse effects RNA, Viral--blood Ritonavir--therapeutic use Treatment Outcome Viral Load--drug effects Young Adult